PharmaVentures is a global leader in life sciences dealmaking—spanning M&A, licensing, valuation and strategy. With 30+ years and 1,000+ clients supported transactions completed, we help clients originate, structure and execute deals that maximise value. Blending deep industry expertise, data-driven insight and a powerful global network, we turn opportunity into competitive advantage, consistently delivering outcomes for both buyers and sellers. For more details, visit https://www.pharmaventures.com
Looking for a particular PharmaVentures employee's phone or email?
The PharmaVentures annual revenue was $6.3 million in 2026.
Fintan Walton is the Chairman and Chief Executive of PharmaVentures.
25 people are employed at PharmaVentures.
The NAICS codes for PharmaVentures are [5231, 52, 523110, 523, 52311].
The SIC codes for PharmaVentures are [621, 62].